Biogen Idec's Fampyra approved in Australia
Links shared publicly online about this topic.
- 289total visits
Biogen Idec's Fampyra approved in Australia
View full resource at boston.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Drug, Biogen Idec
Most Recently Shared on May 16, 2011 at 2:32 pm By:
Biogen Idec's Fampyra approved in Australia: Biogen Idec Inc. said that Australian regulators approved marketing ... http://bo.st/loIdeO
European Commission gives conditional OK for Biogen Idecs MS drug Fampyra
bioportfolio.com — “{thePharmaLetter via BioPortfolio} The European subsidiary of US biotech firm Biogen Idec (Nasdaq: BIIB) has received conditional approval from the European Com...” View full resource at bioportfolio.com
Most Recently Shared on July 26, 2011 at 10:20 am By:
BioPortfolio News European Commission gives conditional OK for Biogen Idecs MS drug Fampyra: T... http://bit.ly/pALBrQ BioPortfolio News
Biogen Idec Receives Conditional Approval In The European Union For FAMPYRA(R) To Improve Walking In Adults With Multiple Sclerosis
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) announced today it has received conditional approval from the European Commission for FAMPYRA® (prolonged-release fampridine tablets) to improve walking in adult pat” View full resource at medicalnewstoday.com
Most Recently Shared on July 25, 2011 at 4:05 pm By:
Biogen Idec Receives Conditional Approval In The European Union For FAMPYRA(R) To Improve Walking In Adults With Multi... http://mnt.to/3Yw5
UPDATE 1-Biogen wins conditional approval for MS drug in EU | Reuters
reuters.com — “* Europe gives conditional approval to Fampyra * Regulators recommend Biogen conduct additional study * Study to evaluate safety, efficacy over the long term BOSTON, July 25 (Reuters) - Biogen Idec” View full resource at reuters.com
Most Recently Shared on July 25, 2011 at 2:17 pm By:
Biogen grabs MS drug OK in EU, http://reut.rs/paQF7I (a feather in $BIIB's cap ahead of earnings this week?)
European Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion On Marketing Authorisation Application For FAMPYRA
medicalnewstoday.com — “Biogen Idec (NASDAQ: BIIB) announced today that FAMPYRA® (prolonged-release fampridine tablets) has been granted a positive opinion for conditional approval from the European Medicines Agency'” View full resource at medicalnewstoday.com
Most Recently Shared on May 20, 2011 at 4:05 pm By:
European Medicines Agency's Committee For Medicinal Products For Human Use Issues Positive Opinion On Marketing Author... http://mnt.to/3W9r
Biogen Idec Receives Approval For FAMPYRA In Australia To Improve Walking Ability In Adult Patients With MS
medicalnewstoday.com — “The Australian Therapeutic Goods Administration (TGA) has granted approval for FAMPYRA™, (fampridine) 10 mg Modified Release (MR) tablet, for the symptomatic improvement of walking ability i” View full resource at medicalnewstoday.com
Most Recently Shared on May 16, 2011 at 2:32 pm By:
Biogen Idec Receives Approval For FAMPYRA In Australia To Improve Walking Ability In Adult Patients With MS: The... http://bit.ly/l6lU0w
Biogen Idec Receives Approval For FAMPYRA In Australia To Improve Walking Ability In Adult Patients With MS
medicalnewstoday.com — “The Australian Therapeutic Goods Administration (TGA) has granted approval for FAMPYRA™, (fampridine) 10 mg Modified Release (MR) tablet, for the symptomatic improvement of walking ability i” View full resource at medicalnewstoday.com
Most Recently Shared on May 16, 2011 at 12:05 pm By:
Biogen Idec Receives Approval For FAMPYRA In Australia To Improve Walking Ability In Adult Patients With MS http://mnt.to/3VTB
Biogen Idec Receives Approval for FAMPYRA in Australia to Improve Walking Ability in Adult Patients with MS - News Press Release | PharmiWeb.com
pharmiweb.com — “Biogen Idec Receives Approval for FAMPYRA in Australia to Improve Walking Ability in Adult Patients with MS - News Press Release | PharmiWeb.com” View full resource at pharmiweb.com
Most Recently Shared on May 16, 2011 at 8:30 am By:
Press Release: The Australian Therapeutic Goods Administration (TGA) has granted approval for FAMPYRAâ„¢, (fampr... http://bit.ly/inzIQb
Biogen Idec Receives Approval for FAMPYRA in Australia to Improve Walking Ability in Adult Patients with MS 16.05.2011 | Nachricht | finanzen.net
finanzen.net — “Biogen Idec Receives Approval for FAMPYRA in Australia to Improve Walking Ability in Adult Patients with MS 16.05.2011 | Nachricht | finanzen.net” View full resource at finanzen.net
Most Recently Shared on May 16, 2011 at 8:30 am By:
Biogen Idec Receives Approval for FAMPYRA in Australia to Improve Walking Ability in Adult Patients with MS: The... http://bit.ly/kg32mD
Advertisement
